ALK-Abello A/S

ALK-Abello A/S Series B
Stock Exchange Other OTC
EPS
$1.5
Market Cap
$2.41 B
Shares Outstanding
9.21 M
Public Float
-
ALK-Abello A/S Series B
Stock Exchange Copenhagen Stock Exchange
EPS
DKK9.64
Market Cap
DKK16.84 B
Shares Outstanding
10.13 M
Public Float
6.44 M

Profile

Address
Bøge Allé 6-8
Hørsholm CR 2970
Denmark
Employees -
Website http://www.alk.net
Updated 07/08/2019
ALK-Abello A/S engages in the production and development of pharmaceutical products to prevent and treat allergies. It also manufactures tablet-based allergy vaccines for pollen, house dust mites, animals, and insect stings. Its treatment comprises allergy vaccines, emergency treatment, and allergy diagnostics.

Financials

View All

Jakob Riis
Director
Katja Barnkob Thalund
Director